SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001626199-23-000098
Filing Date
2023-10-04
Accepted
2023-10-04 17:11:14
Documents
3
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1696453864.html 3  
1 FORM 3 wk-form3_1696453864.xml 3 1692
2 EX-24 powerofattorneywdalpine0.htm EX-24 644
3 powerofattorneywdalpine0001.jpg GRAPHIC 169143
  Complete submission text file 0001626199-23-000098.txt   236927
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5491 OPTICAL CT. SAN JOSE CA 95138
Business Address
Dummer Wolfgang (Reporting) CIK: 0001749991 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 231308854